New study aims to tailor heart treatment for tiniest babies
NCT ID NCT07374146
First seen Feb 01, 2026 · Last updated May 08, 2026 · Updated 12 times
Summary
This study focuses on extremely preterm infants (born before 32 weeks) who have a heart condition called hsPDA, where a blood vessel fails to close after birth. Researchers will collect blood samples and health data to create a model that predicts which babies are at highest risk. They also plan to develop a targeted drug delivery system to treat the condition more precisely. The goal is to improve treatment and reduce side effects for these fragile infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.